Live Quote · NASDAQICADHealthcare· Medical - Devices

iCAD, Inc.

$3.87 3.75%(+$0.14)
TickerSpark Score
75/100
Solid
65
Valuation
40
Profitability
85
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICAD research report →

52-Week Range95% of range
Low
$1.19
Current
$3.87
High
$4.01
Company Overviewwww.icadmed.com

About the company

iCAD, Inc. specializes in delivering advanced solutions for cancer management, encompassing sophisticated image analysis tools, streamlined workflow optimization, and targeted radiation therapy. While primarily operating in the United States, the company also maintains a significant international presence.

CEO
Dana R. Brown
IPO
1984
Employees
66
HQ
Nashua, NH, US

Price Chart

+182.48% · this period
$3.99$2.60$1.20Jul 16Jan 15Jul 17
Valuation
Market Cap
$106.31M
P/E
-18.43
P/S
5.42
P/B
3.56
EV/EBITDA
-18.33
Div Yield
0.00%
Profitability
Gross Margin
84.84%
Op Margin
-31.97%
Net Margin
-28.64%
ROE
-18.09%
ROIC
-20.75%
Growth & Income
Revenue
$19.61M · 13.22%
Net Income
$-5,616,000 · -15.87%
EPS
$-0.21 · 22.22%
Op Income
$-6,268,000
FCF YoY
33.96%
Performance & Tape
52W High
$4.01
52W Low
$1.19
50D MA
$3.77
200D MA
$2.57
Beta
1.40
Avg Volume
789.05K

Get TickerSpark's AI analysis on ICAD

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jul 17, 25Hricak Hedvigsell40,000
Jul 17, 25Hricak Hedvigsell6,641
Jul 17, 25Hricak Hedvigsell5,415
Jul 17, 25Hricak Hedvigsell30,000
Jul 17, 25Go Jonathansell25,000
Jul 17, 25Go Jonathansell14,183
Jul 17, 25Go Jonathansell19,000
Jul 17, 25Go Jonathansell25,000
Jul 17, 25Go Jonathansell50,000
Jul 17, 25Go Jonathansell188,725
Coverage · ICAD

Our ICAD coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ICAD yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ICAD report →
Internal Compare

Similar companies

Peers in the same neighborhood.